| Reference |
|---|
Raymond D, Fukui M, Zwernik S, Kassam A, Rovin R, Akhtar P. Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study. PLoS ONE. 2024;19:e0301739 pubmed publisher |
Xiong Y, Wang B, Jiao J, Tang M, Li K, Jiang R, et al. Expression and clinical association of MFG-E8 and TAM receptors in diabetic patients with different stages of microvascular complication: An experimental study. Medicine (Baltimore). 2023;102:e35788 pubmed publisher |
Nordb xf8 O, Landolt L, Eikrem x, Scherer A, Leh S, Furriol J, et al. Transcriptomic analysis reveals partial epithelial-mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy. Physiol Rep. 2023;11:e15825 pubmed publisher |
Apostolo D, D Onghia D, Tonello S, Minisini R, Baricich A, Gramaglia C, et al. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors. Int J Mol Sci. 2023;24: pubmed publisher |
Tonello S, Rizzi M, Matino E, Costanzo M, Casciaro G, Croce A, et al. Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients. Dis Markers. 2022;2022:1568352 pubmed publisher |
Sch xf6 tt U, Augustsson C, Lilover L, Nilsson C, Walther Sturesson L, Kander T. Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study. Nutrients. 2021;13: pubmed publisher |
Huckriede J, Anderberg S, Morales A, de Vries F, Hultstr xf6 m M, Bergqvist A, et al. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Sci Rep. 2021;11:15701 pubmed publisher |
Vullings J, Vago J, Waterborg C, Thurlings R, Koenders M, van Lent P, et al. Selective Increment of Synovial Soluble TYRO3 Correlates with Disease Severity and Joint Inflammation in Patients with Rheumatoid Arthritis. J Immunol Res. 2020;2020:9690832 pubmed publisher |
Lashkari K, Teague G, Beattie U, Betts J, Kumar S, McLaughlin M, et al. Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration. PLoS ONE. 2020;15:e0236283 pubmed publisher |
Wang S, Li R, Ng T, Luthria G, Oudin M, Prytyskach M, et al. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020;6:eaaz8521 pubmed publisher |
Bellan M, Dimagli A, Piccinino C, Giubertoni A, Ianniello A, Grimoldi F, et al. Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders. Dis Markers. 2020;2020:2696173 pubmed publisher |
Chen C, Peng P, Tsai T, Chien H, Lee M. A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy. Pharmaceutics. 2020;12: pubmed publisher |
Flem Karlsen K, Nyakas M, Farstad I, McFadden E, Wernhoff P, Jacobsen K, et al. Soluble AXL as a marker of disease progression and survival in melanoma. PLoS ONE. 2020;15:e0227187 pubmed publisher |
Tutusaus A, de Gregorio E, Cucarull B, Cristóbal H, Aresté C, Graupera I, et al. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Cell Mol Gastroenterol Hepatol. 2020;9:349-368 pubmed publisher |
Parodis I, Ding H, Zickert A, Cosson G, Fathima M, Grönwall C, et al. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis. PLoS ONE. 2019;14:e0212068 pubmed publisher |
Flem Karlsen K, McFadden E, Flørenes V, Davidson B. Soluble AXL is ubiquitously present in malignant serous effusions. Gynecol Oncol. 2019;152:408-415 pubmed publisher |
García Lucio J, Peinado V, de Jover L, Del Pozo R, Blanco I, Bonjoch C, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS ONE. 2018;13:e0195724 pubmed publisher |
Kurowska Stolarska M, Alivernini S, Melchor E, Elmesmari A, Tolusso B, Tange C, et al. MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis. Nat Commun. 2017;8:15877 pubmed publisher |
Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss K, et al. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. Oncotarget. 2017;8:46234-46248 pubmed publisher |
Stalder G, Que Y, Calzavarini S, Burnier L, Kosinski C, Ballabeni P, et al. Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis. PLoS ONE. 2016;11:e0163542 pubmed publisher |
Kefaloyianni E, Muthu M, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, et al. ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight. 2016;1: pubmed publisher |
Mok C, Ding H, Kharboutli M, Mohan C. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016;68:1303-9 pubmed publisher |
Johansson G, Peng P, Huang P, Chien H, Hua K, Kuo M, et al. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden. PLoS ONE. 2014;9:e115916 pubmed publisher |
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher |
Scutera S, Fraone T, Musso T, Cappello P, Rossi S, Pierobon D, et al. Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway. J Immunol. 2009;183:3004-13 pubmed publisher |
